123 related articles for article (PubMed ID: 25510781)
1. Intralesional 3% sodium tetradecyl sulfate for treatment of cutaneous Kaposi's sarcoma.
Kim JY; Kim JS; Kim MH; Park BC; Hong SP
Yonsei Med J; 2015 Jan; 56(1):307-8. PubMed ID: 25510781
[No Abstract] [Full Text] [Related]
2. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.
Ramírez-Amador V; Esquivel-Pedraza L; Lozada-Nur F; De la Rosa-García E; Volkow-Fernández P; Súchil-Bernal L; Mohar A
Oral Oncol; 2002 Jul; 38(5):460-7. PubMed ID: 12110340
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cutaneous Kaposi's sarcoma with intralesional vincristine.
Odom RB; Goette DK
Arch Dermatol; 1978 Nov; 114(11):1693-4. PubMed ID: 718222
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of classic Kaposi's sarcoma growth after intralesional injections of desferrioxamine.
Simonart T; Boelaert JR; Van Vooren JP
Dermatology; 2002; 204(4):290-2. PubMed ID: 12077524
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of a pseudocyst of the auricle using intralesional sodium tetradecyl sulfate injection.
Lee JY; Yoo CS; Kim CW; Kim SS
Dermatol Surg; 2013 Dec; 39(12):1938-40. PubMed ID: 24299577
[No Abstract] [Full Text] [Related]
6. Treatment of digital mucous cysts with intralesional sodium tetradecyl sulfate injection.
Park SE; Park EJ; Kim SS; Kim CW
Dermatol Surg; 2014 Nov; 40(11):1249-54. PubMed ID: 25285815
[TBL] [Abstract][Full Text] [Related]
7. [Off-label use of vincristine for intralesional treatment of isolated papules in Kaposi's sarcoma: Dermatologic experience with 10 patients].
Peduto T; Fabbrocini G; Delfino M; Nappa P; Guarino M; Cillo F
Ann Dermatol Venereol; 2020 Feb; 147(2):140-143. PubMed ID: 31810583
[No Abstract] [Full Text] [Related]
8. Ultrasonographic intraoperative monitoring and follow-up of Kaposi's sarcoma nodules under treatment with intralesional vincristine.
Nazzaro G; Genovese G; Tourlaki A; Passoni E; Berti E; Brambilla L
Skin Res Technol; 2019 Mar; 25(2):200-203. PubMed ID: 30311687
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Kaposi's sarcoma with vinblastine.
Klein E; Schwartz RA; Laor Y; Milgrom H; Burgess GH; Holtermann OA
Cancer; 1980 Feb; 45(3):427-31. PubMed ID: 7353196
[TBL] [Abstract][Full Text] [Related]
10. Intralesional chemotherapy for Kaposi's sarcoma.
Brambilla L; Boneschi V; Beretta G; Finzi AF
Dermatologica; 1984; 169(3):150-5. PubMed ID: 6207059
[TBL] [Abstract][Full Text] [Related]
11. A juvenile case of classic Kaposi's sarcoma.
Erdem T; Atasoy M; Akdeniz N; Parlak M; Ozdemir S
Acta Derm Venereol; 1999 Nov; 79(6):492-3. PubMed ID: 10598779
[No Abstract] [Full Text] [Related]
12. [Kaposi's sarcoma treated with topical alitretinoin].
González de Arriba A; Pérez-Gala S; Goiriz-Valdés R; Ríos-Buceta L; García-Díez A
Actas Dermosifiliogr; 2007; 98(1):50-3. PubMed ID: 17374335
[TBL] [Abstract][Full Text] [Related]
13. Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients.
Vassallo C; Carugno A; Derlino F; Ciocca O; Brazzelli V; Borroni G
Cutis; 2015 May; 95(5):E28-34. PubMed ID: 26057517
[TBL] [Abstract][Full Text] [Related]
14. Treatment of classical Kaposi's sarcoma with intralesional injections of cidofovir: report of a case.
Simonart T; Noel JC; De Dobbeleer G; Parent D; Van Vooren JP; De Clercq E; Snoeck R
J Med Virol; 1998 Jul; 55(3):215-8. PubMed ID: 9624609
[TBL] [Abstract][Full Text] [Related]
15. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
Boudreaux AA; Smith LL; Cosby CD; Bason MM; Tappero JW; Berger TG
J Am Acad Dermatol; 1993 Jan; 28(1):61-5. PubMed ID: 8381146
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Turiansky G; Wagner KF
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
[TBL] [Abstract][Full Text] [Related]
17. Classic Kaposi's sarcoma treated with topical 0.5% timolol gel.
Alcántara-Reifs CM; Salido-Vallejo R; Garnacho-Saucedo GM; Vélez García-Nieto A
Dermatol Ther; 2016 Sep; 29(5):309-311. PubMed ID: 27329079
[No Abstract] [Full Text] [Related]
18. AIDS-related cutaneous Kaposi's sarcoma: failure of treatment with human chorionic gonadotropin.
Sipsas NV; Aroni K; Tsavaris N; Mavragani K; Paikos S; Kordossis T
J Chemother; 1999 Feb; 11(1):78-9. PubMed ID: 10078786
[No Abstract] [Full Text] [Related]
19. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
Volkow P; Zinser JW; Correa-Rotter R
BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
[TBL] [Abstract][Full Text] [Related]
20. The use of foam sclerotherapy for the treatment of head and neck vascular malformations.
Rehman KU; Sittampalam G; McCafferty I; Monaghan A
Br J Oral Maxillofac Surg; 2009 Dec; 47(8):631-2. PubMed ID: 19375203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
